Richard Treisman

from Wikipedia, the free encyclopedia
Richard Treisman

Richard Treisman (* 1954 ) is a British molecular biologist and biochemist.

Treisman received his PhD from University College London in 1981 with Bob Kamen and was a post-doctoral student with Tom Maniatis at Harvard University . From 1984 he was at the MRC Laboratory of Molecular Biology and from 1988 he had his own laboratory at the Imperial Cancer Research Fund (from 2002 Cancer Research UK), where he became director of laboratory research from 2000 and director of the London Research Institute in 2002. He is Director of Research at the Francis Crick Institute in London.

It deals with signaling pathways in the cell in response to external stimuli. In 1986 he discovered the serum response factor (SRF), a transcription factor that has a gene-regulating effect on many immediate early genes (such as C-Fos ) and there binds to the SRE (serum response element). He further investigated the interaction of SRF with other cofactors such as TCF (Ternary Complex Factor). The SRF signaling pathway is important in cell proliferation and in cell movement and adhesion.

He is a Fellow of the Royal Society and the Academy of Medical Sciences and a member of the European Molecular Biology Organization . In 1999 he was elected a member of the Academia Europaea . In 2002 he received the Louis Jeantet Prize . In 2012 he was elected a Fellow of the American Association for the Advancement of Science . In 2016 he was ennobled.

Web links

Individual evidence

  1. ^ Directory of members: Richard Treisman. Academia Europaea, accessed January 9, 2018 .